Johannes Holtschmidt

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Johannes Holtschmidt

Feb 4, 2025, 15:30 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the Breast Cancer Research Digest - a…

Feb 3, 2025, 17:28 | Science

Yakup Ergün: Surrogate End Points for OS in Neoadjuvant RCTs for Early Breast Cancer

Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X about recent paper by…

Dec 17, 2024, 05:49 | Science

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center posted on X: "Check out the newest Breast Cancer Research Digest…

Dec 13, 2024, 18:20 | Insight

Omission of Surgical Axillary Staging in Clinically Node-Negative T1-T2 Breast Cancer: INSEMA Trial Findings

The results of the INSEMA trial were recently presented at SABCS24. The INSEMA trial evaluated…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023